Company profile
Medical Marijuana, Inc.
OTC: MJNA · Healthcare · Drug Manufacturers - Specialty & Generic
#608 of 1,422 Healthcare companies by revenue29th-percentile growth
EA Score
58CFH 64DQ —GM 47SS 46
v0.1 · 45/100 weight · provisional
↑ growth stability, return on assets · ↓ Piotroski F, 3-yr revenue growth
Methodology →Revenue TTM
$11.8M
Rev growth YoY (TTM)
-7.2%
Net income (FY)
-$935.3k
Employees
22
as of 2026-08-26
Market cap
$1.1M
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$12.5M$12.5M2025
Net income-$935.3k-$935.3k2025
Operating income-$905.5k-$905.5k2025
Total assets$66.3M$66.3M2025
Liabilities$16.5M$16.5M2025
Equity$49.8M$49.8M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Medical Marijuana, Inc.’s revenue?
Medical Marijuana, Inc. booked $12.5M in FY2025 revenue, contracting 16% year over year — slower than 71% of Healthcare companies we track, at a -7.5% net margin.
Peers · Healthcare
Lumos Diagnostics Holdings Ltd.45DNexgenRx Inc.71BClearday, Inc.——Emmaus Life Sciences, Inc.40DElutia Inc52DDevonian Health Group Inc.46DNeighbors
San Diego →Key facts
CEOTimothy Richard Scott
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVista, CA
ExchangeOTC: MJNA
Employees22
IPO date2010-08-06
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.